Solventum Gross Profit 2023-2026 | SOLV

Solventum annual/quarterly gross profit history and growth rate from 2023 to 2026. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  • Solventum gross profit for the quarter ending March 31, 2026 was $1.096B, a 1.62% decline year-over-year.
  • Solventum gross profit for the twelve months ending March 31, 2026 was $4.433B, a 2.25% decline year-over-year.
  • Solventum annual gross profit for 2025 was $4.451B, a 3.09% decline from 2024.
  • Solventum annual gross profit for 2024 was $4.593B, a 2.13% decline from 2023.
  • Solventum annual gross profit for 2023 was $4.693B, a 0.04% decline from 2022.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Solventum Annual Gross Profit
(Millions of US $)
2025 $4,451
2024 $4,593
2023 $4,693
2022 $4,695
Solventum Quarterly Gross Profit
(Millions of US $)
2026-03-31 $1,096
2025-12-31 $1,027
2025-09-30 $1,135
2025-06-30 $1,175
2025-03-31 $1,114
2024-12-31 $1,119
2024-09-30 $1,165
2024-06-30 $1,137
2024-03-31 $1,172
2023-12-31 $1,158
2023-09-30 $1,209
2023-06-30 $1,189
2023-03-31 $1,137
2022-12-31
Sector Industry Market Cap Revenue
Medical Medical Services $11.408B $8.325B
Solventum is an independent healthcare company. Its business segment includes Medical Surgical, Dental Solutions, Health Information Systems and Purification and Filtration. Solventum is based in ST. PAUL, Minn.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $134.187B 24.31
HCA Healthcare (HCA) United States $110.772B 17.53
CVS Health (CVS) United States $101.670B 11.75
Elevance Health (ELV) United States $68.432B 10.33
Cencora (COR) United States $62.409B 19.63
Natera (NTRA) United States $27.358B 0.00
Labcorp Holdings (LH) United States $21.501B 15.87
DiDi Global (DIDIY) China $18.026B 15.96
Viatris (VTRS) United States $15.685B 5.71
EUROFINS SCIENT (ERFSF) Luxembourg $14.535B 0.00
Medpace Holdings (MEDP) United States $14.094B 32.26
BioMerieux (BMXMF) France $12.476B 0.00
Revvity (RVTY) United States $10.039B 17.71
BrightSpring Health Services (BTSG) United States $8.774B 43.59
Charles River Laboratories (CRL) United States $8.667B 17.09
ICON (ICLR) Ireland $8.626B 8.56
CochLear (CHEOY) Australia $8.030B 0.00
Sonic Healthcare (SKHHY) Australia $6.905B 0.00
HealthEquity (HQY) United States $6.586B 23.20
Bausch + Lomb (BLCO) Canada $5.877B 32.98
GETINGE (GNGBY) Sweden $5.626B 17.96
Avantor (AVTR) United States $5.388B 8.68
PACS (PACS) United States $5.304B 27.44
Caris Life Sciences,�Inc (CAI) United States $5.101B 0.00
Sotera Health (SHC) United States $4.380B 19.95
Alignment Healthcare (ALHC) United States $4.188B 0.00
Concentras Parent (CON) United States $2.818B 16.12
Organon (OGN) United States $2.299B 2.57
Amplifon S.p.A (AMFPF) Italy $2.275B 13.27
Pediatrix Medical (MD) United States $1.782B 11.11
Establishment Labs Holdings (ESTA) United States $1.765B 0.00
GeneDx Holdings (WGS) United States $1.746B 42.28
Surgery Partners (SGRY) United States $1.671B 41.65
Sonida Senior Living (SNDA) United States $1.544B 0.00
Ardent Health (ARDT) United States $1.345B 5.70
Progyny (PGNY) United States $1.277B 25.08
Ryman Healthcare (RYHTY) New Zealand $1.240B 0.00
InnovAge Holding (INNV) United States $1.113B 164.00
Teladoc Health (TDOC) United States $0.920B 0.00
CareDx (CDNA) United States $0.822B 0.00
GoodRx Holdings (GDRX) United States $0.750B 12.17
Enhabit (EHAB) United States $0.709B 25.89
Nutex Health (NUTX) United States $0.704B 11.25
Omada Health (OMDA) United States $0.672B 0.00
QDM (QDMI) Hong Kong, SAR China $0.604B 99.85
COMPASS Pathways (CMPS) United Kingdom $0.531B 0.00
Embecta (EMBC) United States $0.524B 2.92
Charming Medical (MCTA) Hong Kong, SAR China $0.497B 0.00
CryoPort (CYRX) United States $0.482B 0.00
Auna S.A (AUNA) Luxembourg $0.435B 4.70
SBC Medicals (SBC) United States $0.426B 8.47
Forward Industries (FWDI) United States $0.375B 0.00
Strata Critical Medical (SRTA) United States $0.349B 0.00
Agilon Health (AGL) United States $0.316B 0.00
Shoulder Innovations (SI) United States $0.309B 0.00
Oncology Institute (TOI) United States $0.304B 0.00
So-Young (SY) China $0.262B 0.00
LifeMD (LFMD) United States $0.166B 0.00
Biodesix (BDSX) United States $0.133B 0.00
Beauty Health (SKIN) United States $0.115B 0.00
Ascend Wellness Holdings (AAWH) United States $0.091B 0.00
Park Dental Partners (PARK) United States $0.080B 0.00
Sera Prognostics (SERA) United States $0.077B 0.00
DocGo (DCGO) United States $0.051B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.037B 0.00
Pomdoctor - (POM) China $0.031B 0.00
IceCure Medical (ICCM) Israel $0.026B 0.00
OSR Holdings (OSRH) United States $0.018B 0.00
SeaStar Medical Holding (ICU) United States $0.015B 0.00
Basel Medical Group (BMGL) Singapore $0.011B 0.00
Lifeward (LFWD) United States $0.010B 0.00
XWELL (XWEL) United States $0.009B 0.00
Aclarion (ACON) United States $0.007B 0.00
Synergy CHC (SNYR) United States $0.007B 0.00
Pheton Holdings (PTHL) China $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
Co-Diagnostics (CODX) United States $0.005B 0.00
Intelligent Bio Solutions (INBS) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
INVO Fertility (IVF) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00